Literature DB >> 1543493

Malignant transformation of rat thyroid cells transfected with the human TSH receptor cDNA.

M Derwahl1, M Broecker, S Aeschimann, H Schatz, H Studer.   

Abstract

Growth and function of well differentiated FRTL-5 thyroid cells depend on thyrotropin as its main regulatory hormone. We demonstrate here that stable transfection of FRTL-5 cells with the human thyrotropin receptor cDNA results in cellular transformation of these cells with altered cell shape and loss of contact inhibition. The transformed cells replicate in soft agar and form invasive tumors when cell suspensions are implanted onto nude mice. They have lost their thyrotropin dependent growth and their ability to concentrate iodide and synthesize thyroglobulin. But they still express the rat thyrotropin receptor mRNA and accumulate cAMP in response to thyrotropin stimulation. However, although the full length human thyrotropin receptor cDNA is integrated into their genome, transformed cells do not express the human thyrotropin receptor mRNA.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1543493     DOI: 10.1016/0006-291x(92)91631-y

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Morphology of FRTL-5 cell colonies in a semi-solid medium.

Authors:  Z Pajer; A Cör; D Stiblar-Martincic
Journal:  J Endocrinol Invest       Date:  2000-04       Impact factor: 4.256

2.  Transfection with the cDNA of the human thyrotropin receptor of a poorly differentiated rat thyroid cell line (FRT).

Authors:  R Elisei; A Pinchera; L Chiovato; C Mammoli; P Agretti; C Romei; F Santini; G Bendinelli; E Fiore; A Capaccioli; P Vitti
Journal:  J Endocrinol Invest       Date:  1996-04       Impact factor: 4.256

3.  Transplantable rat thyroid cancer cell line FRTC transformed with muramyl dipeptide.

Authors:  M Iitaka; N Fukasawa; S Kitahama; S Miura; Y Kawakami; H Sato; S Sugano; J Ishii; S Katayama
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.